Highlights
KLSE: PBBANK (1295)       PUBLIC BANK BHD MAIN : Finance
Last Price Today's Change   Day's Range   Trading Volume
18.52   +0.30 (1.65%)  18.18 - 18.72  1,177,000
Analyze this stock with MQ Trader system

Financials


Market Cap: 71,897 Million

Market Cap 71,897 Million
NOSH 3,882 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 29-May-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 29-May-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Jun-2020 [#2]

Latest Quarter: 30-Jun-2020 [#2]
Announcement Date 28-Aug-2020
Next Quarter: 30-Sep-2020
Est. Ann. Date: 07-Nov-2020
Est. Ann. Due Date: 29-Nov-2020
QoQ | YoY   -24.62%  |    -24.84%

Annual (Unaudited) ( EPS: 141.97, P/E: 13.04 )

Revenue | NP to SH 22,454,734  |  5,511,558
RPS | P/RPS 578.41 Cent  |  3.20
EPS | P/E | EY 141.97 Cent  |  13.04  |  7.67%
DPS | DY | Payout % 73.00 Cent  |  3.94%  |  51.42%
NAPS | P/NAPS 11.23  |  1.65
YoY   -1.41%
NP Margin | ROE 24.85%  |  12.64%
F.Y. | Ann. Date 31-Dec-2019  |  26-Feb-2020

T4Q Result ( EPS: 131.36, P/E: 14.10 )

Revenue | NP to SH 21,542,766  |  5,099,430
RPS | P/RPS 554.92 Cent  |  3.34
EPS | P/E | EY 131.36 Cent  |  14.10  |  7.09%
DPS | DY | Payout % 40.00 Cent  |  2.16%  |  30.45%
NAPS | P/NAPS 11.51  |  1.61
QoQ | YoY   -6.10%  |    -7.82%
NP Margin | ROE 23.92%  |  11.41%
F.Y. | Ann. Date 30-Jun-2020  |  28-Aug-2020

Annualized Result ( EPS: 120.08, P/E: 15.42 )

Revenue | NP to SH 20,508,690  |  4,661,822
RPS | P/RPS 528.28 Cent  |  3.51
EPS | P/E | EY 120.08 Cent  |  15.42  |  6.48%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -12.31%  |    -15.02%
NP Margin | ROE 22.95%  |  10.43%
F.Y. | Ann. Date 30-Jun-2020  |  28-Aug-2020




Show?  YoY % Horiz. %

Last 10 FY Result
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 20,508,690 21,542,766 22,454,734 22,041,785 20,858,174 20,102,740 19,181,550 16,860,071 15,264,300 14,058,097 12,756,360 11,035,597 8.21%
  YoY % -4.80% -4.06% 1.87% 5.67% 3.76% 4.80% 13.77% 10.45% 8.58% 10.20% 15.59% -
  Horiz. % 185.84% 195.21% 203.48% 199.73% 189.01% 182.16% 173.82% 152.78% 138.32% 127.39% 115.59% 100.00%
PBT 6,015,036 6,591,828 7,134,144 7,101,165 7,117,672 6,554,032 6,491,395 5,814,255 5,309,984 5,047,234 4,877,939 4,086,197 6.38%
  YoY % -8.75% -7.60% 0.46% -0.23% 8.60% 0.96% 11.65% 9.50% 5.21% 3.47% 19.38% -
  Horiz. % 147.20% 161.32% 174.59% 173.78% 174.19% 160.39% 158.86% 142.29% 129.95% 123.52% 119.38% 100.00%
Tax -1,307,952 -1,439,248 -1,554,701 -1,436,253 -1,570,693 -1,286,597 -1,370,156 -1,250,915 -1,204,342 -1,177,992 -1,153,436 -987,120 5.17%
  YoY % 9.12% 7.43% -8.25% 8.56% -22.08% 6.10% -9.53% -3.87% -2.24% -2.13% -16.85% -
  Horiz. % 132.50% 145.80% 157.50% 145.50% 159.12% 130.34% 138.80% 126.72% 122.01% 119.34% 116.85% 100.00%
NP 4,707,084 5,152,580 5,579,443 5,664,912 5,546,979 5,267,435 5,121,239 4,563,340 4,105,642 3,869,242 3,724,503 3,099,077 6.75%
  YoY % -8.65% -7.65% -1.51% 2.13% 5.31% 2.85% 12.23% 11.15% 6.11% 3.89% 20.18% -
  Horiz. % 151.89% 166.26% 180.04% 182.79% 178.99% 169.97% 165.25% 147.25% 132.48% 124.85% 120.18% 100.00%
NP to SH 4,661,822 5,099,430 5,511,558 5,590,611 5,470,035 5,206,875 5,062,152 4,518,830 4,064,683 3,826,754 3,684,289 3,048,224 6.80%
  YoY % -8.58% -7.48% -1.41% 2.20% 5.05% 2.86% 12.02% 11.17% 6.22% 3.87% 20.87% -
  Horiz. % 152.94% 167.29% 180.81% 183.41% 179.45% 170.82% 166.07% 148.24% 133.35% 125.54% 120.87% 100.00%
Tax Rate 21.74 % 21.83 % 21.79 % 20.23 % 22.07 % 19.63 % 21.11 % 21.51 % 22.68 % 23.34 % 23.65 % 24.16 % -1.14%
  YoY % -0.41% 0.18% 7.71% -8.34% 12.43% -7.01% -1.86% -5.16% -2.83% -1.31% -2.11% -
  Horiz. % 89.98% 90.36% 90.19% 83.73% 91.35% 81.25% 87.38% 89.03% 93.87% 96.61% 97.89% 100.00%
Total Cost 15,801,606 16,390,186 16,875,291 16,376,873 15,311,195 14,835,305 14,060,311 12,296,731 11,158,658 10,188,855 9,031,857 7,936,520 8.74%
  YoY % -3.59% -2.87% 3.04% 6.96% 3.21% 5.51% 14.34% 10.20% 9.52% 12.81% 13.80% -
  Horiz. % 199.10% 206.52% 212.63% 206.35% 192.92% 186.92% 177.16% 154.94% 140.60% 128.38% 113.80% 100.00%
Net Worth 44,698,551 44,698,551 43,594,471 40,972,865 37,364,587 34,213,222 31,230,991 28,024,793 20,424,279 18,019,016 15,721,970 13,011,769 14.37%
  YoY % 0.00% 2.53% 6.40% 9.66% 9.21% 9.55% 11.44% 37.21% 13.35% 14.61% 20.83% -
  Horiz. % 343.52% 343.52% 335.04% 314.89% 287.16% 262.94% 240.02% 215.38% 156.97% 138.48% 120.83% 100.00%
Dividend
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Div - 1,552,855 2,833,960 2,678,675 2,355,511 2,239,666 2,162,436 2,085,206 1,821,157 1,751,119 1,680,969 2,027,953 3.79%
  YoY % 0.00% -45.21% 5.80% 13.72% 5.17% 3.57% 3.70% 14.50% 4.00% 4.17% -17.11% -
  Horiz. % 0.00% 76.57% 139.74% 132.09% 116.15% 110.44% 106.63% 102.82% 89.80% 86.35% 82.89% 100.00%
Div Payout % - % 30.45 % 51.42 % 47.91 % 43.06 % 43.01 % 42.72 % 46.14 % 44.80 % 45.76 % 45.63 % 66.53 % -2.82%
  YoY % 0.00% -40.78% 7.33% 11.26% 0.12% 0.68% -7.41% 2.99% -2.10% 0.28% -31.41% -
  Horiz. % 0.00% 45.77% 77.29% 72.01% 64.72% 64.65% 64.21% 69.35% 67.34% 68.78% 68.59% 100.00%
Equity
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Net Worth 44,698,551 44,698,551 43,594,471 40,972,865 37,364,587 34,213,222 31,230,991 28,024,793 20,424,279 18,019,016 15,721,970 13,011,769 14.37%
  YoY % 0.00% 2.53% 6.40% 9.66% 9.21% 9.55% 11.44% 37.21% 13.35% 14.61% 20.83% -
  Horiz. % 343.52% 343.52% 335.04% 314.89% 287.16% 262.94% 240.02% 215.38% 156.97% 138.48% 120.83% 100.00%
NOSH 3,882,138 3,882,138 3,882,138 3,882,138 3,861,494 3,861,494 3,861,494 3,861,494 3,502,225 3,502,238 3,502,020 3,496,471 1.17%
  YoY % 0.00% 0.00% 0.00% 0.53% 0.00% 0.00% 0.00% 10.26% -0.00% 0.01% 0.16% -
  Horiz. % 111.03% 111.03% 111.03% 111.03% 110.44% 110.44% 110.44% 110.44% 100.16% 100.16% 100.16% 100.00%
Ratio Analysis
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin 22.95 % 23.92 % 24.85 % 25.70 % 26.59 % 26.20 % 26.70 % 27.07 % 26.90 % 27.52 % 29.20 % 28.08 % -1.35%
  YoY % -4.06% -3.74% -3.31% -3.35% 1.49% -1.87% -1.37% 0.63% -2.25% -5.75% 3.99% -
  Horiz. % 81.73% 85.19% 88.50% 91.52% 94.69% 93.30% 95.09% 96.40% 95.80% 98.01% 103.99% 100.00%
ROE 10.43 % 11.41 % 12.64 % 13.64 % 14.64 % 15.22 % 16.21 % 16.12 % 19.90 % 21.24 % 23.43 % 23.43 % -6.62%
  YoY % -8.59% -9.73% -7.33% -6.83% -3.81% -6.11% 0.56% -18.99% -6.31% -9.35% 0.00% -
  Horiz. % 44.52% 48.70% 53.95% 58.22% 62.48% 64.96% 69.18% 68.80% 84.93% 90.65% 100.00% 100.00%
Per Share
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 528.28 554.92 578.41 567.77 540.16 520.59 496.74 436.62 435.85 401.40 364.26 315.62 6.96%
  YoY % -4.80% -4.06% 1.87% 5.11% 3.76% 4.80% 13.77% 0.18% 8.58% 10.20% 15.41% -
  Horiz. % 167.38% 175.82% 183.26% 179.89% 171.14% 164.94% 157.39% 138.34% 138.09% 127.18% 115.41% 100.00%
EPS 120.08 131.36 141.97 144.37 141.66 134.84 131.09 123.74 116.06 109.27 105.20 87.18 5.56%
  YoY % -8.59% -7.47% -1.66% 1.91% 5.06% 2.86% 5.94% 6.62% 6.21% 3.87% 20.67% -
  Horiz. % 137.74% 150.68% 162.85% 165.60% 162.49% 154.67% 150.37% 141.94% 133.13% 125.34% 120.67% 100.00%
DPS 0.00 40.00 73.00 69.00 61.00 58.00 56.00 54.00 52.00 50.00 48.00 58.00 2.59%
  YoY % 0.00% -45.21% 5.80% 13.11% 5.17% 3.57% 3.70% 3.85% 4.00% 4.17% -17.24% -
  Horiz. % 0.00% 68.97% 125.86% 118.97% 105.17% 100.00% 96.55% 93.10% 89.66% 86.21% 82.76% 100.00%
NAPS 11.5139 11.5139 11.2295 10.5542 9.6762 8.8601 8.0878 7.2575 5.8318 5.1450 4.4894 3.7214 13.05%
  YoY % 0.00% 2.53% 6.40% 9.07% 9.21% 9.55% 11.44% 24.45% 13.35% 14.60% 20.64% -
  Horiz. % 309.40% 309.40% 301.75% 283.61% 260.02% 238.09% 217.33% 195.02% 156.71% 138.25% 120.64% 100.00%
Adjusted Per Share Value based on latest NOSH - 3,882,138
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
RPS 528.28 554.92 578.41 567.77 537.29 517.83 494.10 434.30 393.19 362.12 328.59 284.27 8.21%
  YoY % -4.80% -4.06% 1.87% 5.67% 3.76% 4.80% 13.77% 10.46% 8.58% 10.20% 15.59% -
  Horiz. % 185.84% 195.21% 203.47% 199.73% 189.01% 182.16% 173.81% 152.78% 138.32% 127.39% 115.59% 100.00%
EPS 120.08 131.36 141.97 144.37 140.90 134.12 130.40 116.40 104.70 98.57 94.90 78.52 6.80%
  YoY % -8.59% -7.47% -1.66% 2.46% 5.06% 2.85% 12.03% 11.17% 6.22% 3.87% 20.86% -
  Horiz. % 152.93% 167.29% 180.81% 183.86% 179.44% 170.81% 166.07% 148.24% 133.34% 125.53% 120.86% 100.00%
DPS 0.00 40.00 73.00 69.00 60.68 57.69 55.70 53.71 46.91 45.11 43.30 52.24 3.79%
  YoY % 0.00% -45.21% 5.80% 13.71% 5.18% 3.57% 3.71% 14.50% 3.99% 4.18% -17.11% -
  Horiz. % 0.00% 76.57% 139.74% 132.08% 116.16% 110.43% 106.62% 102.81% 89.80% 86.35% 82.89% 100.00%
NAPS 11.5139 11.5139 11.2295 10.5542 9.6247 8.8130 8.0448 7.2189 5.2611 4.6415 4.0498 3.3517 14.37%
  YoY % 0.00% 2.53% 6.40% 9.66% 9.21% 9.55% 11.44% 37.21% 13.35% 14.61% 20.83% -
  Horiz. % 343.52% 343.52% 335.04% 314.89% 287.16% 262.94% 240.02% 215.38% 156.97% 138.48% 120.83% 100.00%
Price Multiplier on Financial Quarter End Date
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date AQR T4Q 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 -
Price 16.5000 16.5000 19.4400 24.7600 20.7800 19.7200 18.5200 18.3000 19.4000 16.2800 13.3800 13.0200 -
P/RPS 3.12 2.97 3.36 4.36 3.85 3.79 3.73 4.19 4.45 4.06 3.67 4.13 -2.27%
  YoY % 5.05% -11.61% -22.94% 13.25% 1.58% 1.61% -10.98% -5.84% 9.61% 10.63% -11.14% -
  Horiz. % 75.54% 71.91% 81.36% 105.57% 93.22% 91.77% 90.31% 101.45% 107.75% 98.31% 88.86% 100.00%
P/EPS 13.74 12.56 13.69 17.19 14.67 14.62 14.13 15.64 16.72 14.90 12.72 14.93 -0.96%
  YoY % 9.39% -8.25% -20.36% 17.18% 0.34% 3.47% -9.65% -6.46% 12.21% 17.14% -14.80% -
  Horiz. % 92.03% 84.13% 91.69% 115.14% 98.26% 97.92% 94.64% 104.76% 111.99% 99.80% 85.20% 100.00%
EY 7.28 7.96 7.30 5.82 6.82 6.84 7.08 6.39 5.98 6.71 7.86 6.70 0.96%
  YoY % -8.54% 9.04% 25.43% -14.66% -0.29% -3.39% 10.80% 6.86% -10.88% -14.63% 17.31% -
  Horiz. % 108.66% 118.81% 108.96% 86.87% 101.79% 102.09% 105.67% 95.37% 89.25% 100.15% 117.31% 100.00%
DY 0.00 2.42 3.76 2.79 2.94 2.94 3.02 2.95 2.68 3.07 3.59 4.45 -1.85%
  YoY % 0.00% -35.64% 34.77% -5.10% 0.00% -2.65% 2.37% 10.07% -12.70% -14.48% -19.33% -
  Horiz. % 0.00% 54.38% 84.49% 62.70% 66.07% 66.07% 67.87% 66.29% 60.22% 68.99% 80.67% 100.00%
P/NAPS 1.43 1.43 1.73 2.35 2.15 2.23 2.29 2.52 3.33 3.16 2.98 3.50 -7.53%
  YoY % 0.00% -17.34% -26.38% 9.30% -3.59% -2.62% -9.13% -24.32% 5.38% 6.04% -14.86% -
  Horiz. % 40.86% 40.86% 49.43% 67.14% 61.43% 63.71% 65.43% 72.00% 95.14% 90.29% 85.14% 100.00%
Price Multiplier on Announcement Date
AQR T4Q 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Date AQR T4Q 26/02/20 20/02/19 22/02/18 02/02/17 03/02/16 05/02/15 05/02/14 06/02/13 30/01/12 25/01/11 -
Price 16.4200 16.4200 17.4800 25.0600 22.2800 20.1400 18.3800 18.4400 19.0600 15.7200 13.5200 13.3400 -
P/RPS 3.11 2.96 3.02 4.41 4.12 3.87 3.70 4.22 4.37 3.92 3.71 4.23 -3.67%
  YoY % 5.07% -1.99% -31.52% 7.04% 6.46% 4.59% -12.32% -3.43% 11.48% 5.66% -12.29% -
  Horiz. % 73.52% 69.98% 71.39% 104.26% 97.40% 91.49% 87.47% 99.76% 103.31% 92.67% 87.71% 100.00%
P/EPS 13.67 12.50 12.31 17.40 15.73 14.94 14.02 15.76 16.42 14.39 12.85 15.30 -2.39%
  YoY % 9.36% 1.54% -29.25% 10.62% 5.29% 6.56% -11.04% -4.02% 14.11% 11.98% -16.01% -
  Horiz. % 89.35% 81.70% 80.46% 113.73% 102.81% 97.65% 91.63% 103.01% 107.32% 94.05% 83.99% 100.00%
EY 7.31 8.00 8.12 5.75 6.36 6.70 7.13 6.35 6.09 6.95 7.78 6.54 2.43%
  YoY % -8.63% -1.48% 41.22% -9.59% -5.07% -6.03% 12.28% 4.27% -12.37% -10.67% 18.96% -
  Horiz. % 111.77% 122.32% 124.16% 87.92% 97.25% 102.45% 109.02% 97.09% 93.12% 106.27% 118.96% 100.00%
DY 0.00 2.44 4.18 2.75 2.74 2.88 3.05 2.93 2.73 3.18 3.55 4.35 -0.44%
  YoY % 0.00% -41.63% 52.00% 0.36% -4.86% -5.57% 4.10% 7.33% -14.15% -10.42% -18.39% -
  Horiz. % 0.00% 56.09% 96.09% 63.22% 62.99% 66.21% 70.11% 67.36% 62.76% 73.10% 81.61% 100.00%
P/NAPS 1.43 1.43 1.56 2.37 2.30 2.27 2.27 2.54 3.27 3.06 3.01 3.58 -8.81%
  YoY % 0.00% -8.33% -34.18% 3.04% 1.32% 0.00% -10.63% -22.32% 6.86% 1.66% -15.92% -
  Horiz. % 39.94% 39.94% 43.58% 66.20% 64.25% 63.41% 63.41% 70.95% 91.34% 85.47% 84.08% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.
  5 people like this.
 
mf tp 21.90
19/11/2020 11:31 AM
Roy 8 Extract from Kingsley Investment Kingsley Investment

.....Not to say not to buy the outbreak beneficiary shares, but the outbreak recovery stocks in 2021 is bound to be a part of the layout, if the worst-case scenario has passed, now every vaccine news on the outbreak recovery stocks will only be good, the small editor only this month began to lay out the recovery stocks, from three different areas of the selection of three companies, namely the financial industry Public Bank, the gambling industry Genting, and the F and B shares Carlsberg, These three companies now account for nearly 30% of the small portfolio, in the future if the share price falls, the small editor will continue to increase positions to adjust the three positions to about 35% of the total position.


All three are well-known companies, and if the financial sector is certainly the first to benefit from the economic recovery, why choose PBB in the total number of bank stocks, because the quality of PBB's own assets is the best in the total number of banks, the average non-performing loan NPL rate of all banks is 1.4% but PBB's NPL rate is the lowest of all banks, only 0.4% of total loans, On behalf of PBB lending rigour and the quality of loans are the best in the banking industry, and this year has made a series of bad debt provisions, for 2021 may produce bad debts have been a preventive shot, if previously complained that the Volkswagen share price is too expensive to buy, now the share price may be a good time to enter the market, compared to the peak of 26 pieces, has been discounted by 30%. Small editor for PBB just made a very small position layout, after all, even if the banking industry back to the pre-epidemic level, the future growth is limited, but also to face the new era of Fintech and E-Wallet competitors to eat, but if the investors who want to stabilize PBB is a good choice.
19/11/2020 11:43 AM
supersinginvestor Bought more ..nice price to top up n keep for kids. Dont think this price will come again
19/11/2020 11:46 AM
AllYouCanBuy All banks are undergoing healthy correction today.. Whoever missed the boat last week your chances are today :)
19/11/2020 11:55 AM
DestinyL Lol I think the downtrend not yet stopped, at least for PBB.
EPF needs to collect cash.
Nice drop today, bought back 10 lots thus far.
19/11/2020 11:59 AM
mf 19 Nov | 11:40amHighlight
Maybank IB Research raises RHB Bank target price to RM6.20
19/11/2020 12:06 PM
ali baba https://www.thestar.com.my/business/business-news/2020/11/19/public-bank-hl-bank-top-scorers-against-credit-risks
19/11/2020 1:04 PM
supersinginvestor Losers in gloves still in denial...
Gloves facing a slow and steady decline back to pre covid levels. They cant see it...they will soon enough....
Flow into bank n pbbank has aldy began...enjoy the journey up...soon upgrades from ibs will come for pbbank...muahahaha
19/11/2020 1:32 PM
loneranger3211 those escaped from gloves, jumping into the banking pool today? Oh my...PBB up and down like crazy!!
19/11/2020 1:35 PM
AllYouCanBuy https://www.theedgemarkets.com/article/public-bank-hong-leong-bank-most-defensive-against-credit-risks-%E2%80%94-cgscimb#.X7YC9vtdxj4.facebook Congratulations to PBB!!
19/11/2020 2:03 PM
AllYouCanBuy Soon Public Bank will be Top 1 in BURSA!!
19/11/2020 2:06 PM
supersinginvestor Yes agree thats wat i have been saying...these two banks will go bak to highs n beyond...buy n hold...
19/11/2020 2:09 PM
AllYouCanBuy Among them Public has the stronger fundamentals. It is self-explanatory in the share prices. Pbb share value is RM1. 30 to RM1.50 above hlb.
19/11/2020 2:13 PM
dusti PLEASE REREAD MY COMMENT AT 10.42 AM YESTERDAY. WHAT HAS HAPPENED SINCE IS THAT FAITHFUL FANS OF PBB IS ENCOURAGING OTHERS TO BUY TO KEEP PRICE FROM DIVING LIKE THIS MORNING. YOU CANT DOTHIS FOREVER IF THE PULL IS SOUTHWARDS. RTHOSE WHO WANT TO BUY, STAND BACK FOR A WHILE AND LET THE PRICE DRIFT. IF IT GOES YOUR WAY, GOOD, BUY IF NOT YOU ARE NOT SADDLED WITH A HEAVY WEIGHT.
THE ECONOMY DOES NOT SIGNAL BANKS TO BECOME RAGING BULLS; PRETEND CAN, NOTHING MORE. THINK FOR YOURSELF BEFORE YOU ACT. CHEERS & GOOD LUCK!
19/11/2020 2:30 PM
DestinyL I'll continue to buy only if it goes down further
19/11/2020 5:31 PM
Sharefisher Meaningful correction done.. Good for future up trend.
19/11/2020 6:23 PM
AllYouCanBuy TP 20.60
19/11/2020 9:05 PM
awesome20 bank will make green klci tomorrow
19/11/2020 9:07 PM
AllYouCanBuy Pfizer and BioNTech will get emergency use approval from the FDA by the end of November. Moderna will follow closely behind. Inoculations will begin in the US in December. Priority given to the frontliners and high risk groups.

Oxford vaccine will have a few more weeks to complete the final trial too. Data has shown an impressive immunity response among the elderly, with minor or no side effects, both are the benchmarks of an effective vaccine.

There will be a wall of vaccines.
19/11/2020 9:33 PM
Sharefisher Just hope pbb moves up slowly. 细水长流
19/11/2020 9:43 PM
DestinyL Politicians stirring again, another reason for red Friday
20/11/2020 7:23 AM
tkl88 Malaysia in deal with China for Covid-19 vaccine development
PUBLISHED : 18 NOV 2020 AT 19:40
WRITER: REUTERS

https://www.bangkokpost.com/world/2021843/malaysia-in-deal-with-china-for-covid-19-vaccine-development

KUALA LUMPUR: Malaysia said on Wednesday it has signed an agreement with China to cooperate on the development of a safe and efficacious vaccine, as part of efforts to combat the Covid-19 pandemic.

Under the agreement, in force for an initial period of five years, the Southeast Asian nation will be given priority access to Covid-19 vaccines developed by China. Both will share knowledge and expertise and facilitate scientific and technological capabilities to advance vaccine development in their countries, Malaysia said in a joint ministerial statement.
Science, Technology and Innovation Minister Khairy Jamaluddin signed the agreement with his Chinese counterpart Wang Zhigang in a virtual ceremony.

Cooperation between Malaysia and China under the agreement would be supervised by a committee chaired by the foreign affairs ministers of both countries that was formed in October to address post-pandemic challenges.

"Both countries will also support the participation of their public and private sectors including universities, institutions, societies and organisations in joint collaborative projects," the Malaysian ministries said.
20/11/2020 7:58 AM
tkl88 Khairy: Malaysia to pay RM94mil upfront for vaccine under Covax plan

* NATION
* Thursday, 19 Nov 2020 
10:53 AM MYT By MARTIN CARVALHO, RAHIMY RAHIM and TARRENCE TAN

https://www.thestar.com.my/news/nation/2020/11/19/khairy-malaysia-to-pay-upfront-rm94mil-for-vaccine-under-covax-plan
20/11/2020 8:38 AM
Roy 8 EPF is buying again!
20/11/2020 9:06 AM
DestinyL Don't be fooled, even though it is net buying.
What you cannot see is buy at what price and sold at what price level.
20/11/2020 9:14 AM
Papayashot epf got many fund managers. It is not surprising if they buy/sell at the same time
20/11/2020 3:32 PM
aarontan1987 at least destiny talk some sense into the discussion not blindly following the public buying when the big boss EPF is buying hahahahahahahaha
20/11/2020 3:56 PM
aarontan1987 fail to achieve 19 u will see a steadfast decline to near 15 soon hahahahahahaha 19 VA has 12,500% holdings while 15 has 90,000% holdings hahahahahahahaha
20/11/2020 3:59 PM
InsiderShark Will the market crash if budget 2021 cannot be passed this coming Thursday (26/10/2020)? These are the 4 possible scenarios:

1. Parliament will be dissolved and a snap election will be called
2. A state of Emergency in the whole country will be declared by YDPA
3. Muhyiddin will resign and YDPA will appoint an interim PM
4. YDPA will appoint a new PM who has majority MPs support. A new budget 2021 also will be tabled by the new appointed PM.

Will the market go down? Will it crash? Take profit now or wait?
20/11/2020 6:01 PM
AllYouCanBuy Covid Vaccines Soon
BioNTech (BTNX) and Pfizer (PFE) plan to file for emergency FDA approval on Friday. The Moderna coronavirus vaccine might follow next week.

Both the Pfizer/BioNTech and Moderna (MRNA) coronavirus vaccines, which use similar mRNA technology, are roughly 95% effective, a high level.

AstraZeneca (AZN) said Thursday that its coronavirus vaccine was safe and triggered an immune system response in a Phase 2 trial. Final-stage trials are underway.

The chief scientific officer for Johnson & Johnson (JNJ) said Thursday that he expects the Dow giant to have enough data for its coronavirus vaccine to seek FDA approval in January or February.

So there's a decent chance that four coronavirus vaccines will be approved by the end of February, facilitating mass vaccinations.

Investors'BusinessDaily. 20/11/2020.
20/11/2020 7:31 PM
supersinginvestor @insidershark

Is the boogeyman hiding in your cupboard under the bed in the basement in ur backyard?
Well we will never know..all we know is cash is shiit..n if u investbin bursa u buy the best..n thats pbbank...buy n hold come what may is my strategy.....
20/11/2020 7:41 PM
gongkia 15 16 17 was a good price to buy.
20/11/2020 10:44 PM
OldWiseMan100 Price correction coming as shown in TA chart. RSI at 80% all time high. MACD all time high and about to cross like previous crossing. Volume down
21/11/2020 1:34 PM
Taikoh Is the boogeyman hiding in your cupboard under the bed in the basement in ur backyard? That is classic bro .....ha..ha...ha
22/11/2020 8:44 AM
BatteriesNotIncluded Price correction coming as shown in TA chart. RSI at 80% all time high. MACD all time high and about to cross like previous crossing. Volume down
22/11/2020 2:02 PM
LongTermInvestor8 Will the market crash if budget 2021 cannot be passed this coming Thursday (26/10/2020)? These are the 4 possible scenarios:

1. Parliament will be dissolved and a snap election will be called
2. A state of Emergency in the whole country will be declared by YDPA
3. Muhyiddin will resign and YDPA will appoint an interim PM
4. YDPA will appoint a new PM who has majority MPs support. A new budget 2021 also will be tabled by the new appointed PM.

Will the market go down? Will it crash? Take profit now or wait?
22/11/2020 4:23 PM
flyingtomoon2020 Pbbank gogogo
22/11/2020 4:26 PM
flyingtomoon2020 Post removed. Why?
22/11/2020 4:27 PM
AllYouCanBuy In the European markets oil and gas counters led the gains last week as almost all sectors have entered the positive territory.
23/11/2020 8:36 AM
AllYouCanBuy RM0.00:23/11 Singapore 3Q GDP fell 5.8% on-year vs earlier estimate 7% drop, govt sees economy growing 4% to 6% next year: Reuters/STARBIZ
23/11/2020 8:36 AM
Roy 8 Malaysian economy should also grows at a similar rate next year.
23/11/2020 10:54 AM
DestinyL EPF selling again
23/11/2020 10:08 PM
tkl88 Wow, oil price continue it’s bull run !
As at 12.30am,
Nymex=> $42.85 ‪(+0.43) (+1.01 %)‬
Brent => $45.80 ‪(+0.73) (+1.62 %)‬

‪Huat ah ! Heng ah ! Ong ah !‬
24/11/2020 2:28 AM
AllYouCanBuy Today will go back up, after a continuous 3 days correction.
24/11/2020 8:45 AM
Roy 8 Positive developments in US; good for the economy around the world. Trump has finally given up his fight to be president for the next 4 years. More stimulation measure of US$ 2 trillion....
24/11/2020 9:18 AM
supersinginvestor Gloves r over. Better buy banks

Sure supermx oso got cases.maybe the gloves need vaccine n not vaccine need gloves ..ahahahahshs
24/11/2020 9:21 AM
Sharefisher Supersinginvestor, you try to post it in glove forums.... Lol. Haha...
24/11/2020 9:27 AM
supersinginvestor Hehe. It was a joke..cos gloves guys keep saying vaccine need gloves now looks like gloves need vaccine..
I dont care about gloves.. out of it aldy...will buy back once hype is over.....
24/11/2020 9:32 AM
Sharefisher Currently, covid is not so scary as compared to the situation in last March. Confidence is coming back soon. Next year will be very much better.
24/11/2020 9:50 AM
supersinginvestor Yes a enjoy gloves 2 rides..2 weeks ago sold all n into banks scientx mkh n a few plantations..looks doing much better..hehe..yippi
24/11/2020 10:01 AM